Beone Medicines Ltd. current report, 25 April 2023

Beigene, Ltd. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Beigene, Ltd. on April 25, 2023. The filing serves to disclose the submission of the Company's 2022 Annual Report to the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange. The reporting period covered is the year ended December 31, 2022.

Key Financial Metrics

The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it references Exhibit 99.1, which contains financial information prepared under U.S. GAAP, including gross profit margin ratios and research and development expenses allocated by key products. The primary financial data referenced in the text is prepared under PRC GAAP and is contained within the separate STAR Annual Report available in Chinese on the Shanghai Stock Exchange website.

Material Changes and Accounting Differences

The filing highlights that the financial information prepared under PRC GAAP differs from U.S. GAAP. Exhibit 99.1 provides a summary of these material differences. No specific operational changes or year-over-year financial variances are detailed within the body of this 8-K document.

Guidance, Outlook, and Risks

The document does not contain management commentary, forward-looking guidance, or specific risk factors. It explicitly states that the STAR Annual Report and the information on the Shanghai Stock Exchange website are not part of this U.S. filing and are not deemed filed with the SEC. The information furnished in Item 2.02 and Exhibit 99.1 is not subject to the liabilities of Section 18 of the Exchange Act.

Investor Verification Checklist

  • Verify the specific U.S. GAAP financial figures in Exhibit 99.1, as they are not listed in the main text.
  • Review the summary of material differences between PRC GAAP and U.S. GAAP provided in Exhibit 99.1.
  • Access the full 2022 STAR Annual Report on the Shanghai Stock Exchange website (www.sse.com.cn) for the complete PRC GAAP financial statements, noting the document is in Chinese only.
  • Confirm that the financial data in this 8-K is furnished for informational purposes and not "filed" for liability purposes under Section 18 of the Exchange Act.